Raymedica, Inc. Releases Evaluation of the Biomechanical Performance of the HydraFlex(TM) Nucleus Arthroplasty(TM) Technology

MINNEAPOLIS--(BUSINESS WIRE)--Raymedica, the Pioneer in Nucleus Arthroplasty, announced today that it will present the biomechanical performance of its HydraFlex Nucleus Arthroplasty Technology at Spine Arthroplasty Society 7th (SAS7) Annual Conference in Berlin, Germany. The HydraFlex Technology was biomechanically evaluated to replicate the anticipated clinical performance. These results will be presented at the Raymedica SAS7 Workshop, May 2nd, Salon 16, Riga Room at 12:30 – 2:00 PM
MORE ON THIS TOPIC